Atlas Venture Opportunity Fund II, L.P. is 10% Owner at Dyne Therapeutics, Inc. (DYN). They have made 1 open-market trade across 1 company since 2022, most recently 2022-12-12.
CIK 0001885327
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10.0M since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DYN | 934,581 | $13.3M |
Shares reported on the most recent Form 4, priced at the 2022-12-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DYN | BUY | 2022-12-12 | 2022-12-14 | $10.70 | $10.0M | -20.4% | -8.0% | -4.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.